Thoracic aortic aneurysm is typically clinically silent, with a natural history of progressive enlargement until a potentially lethal complication such as rupture or dissection occurs. Underlying genetic predisposition strongly influences the risk of thoracic aortic aneurysm and dissection. Familial cases are more virulent, have a higher rate of aneurysm growth, and occur earlier in life. To date, over 30 genes have been associated with syndromic and non-syndromic thoracic aortic aneurysm and dissection. The causative genes and their specific variants help to predict the disease phenotype, including age at presentation, risk of dissection at small aortic sizes, and risk of other cardiovascular and systemic manifestations. This genetic “dictionary” is already a clinical reality, allowing us to personalize care based on specific causative mutations for a substantial proportion of these patients. Widespread genetic sequencing of thoracic aortic aneurysm and dissection patients has been and continues to be crucial to the rapid expansion of this dictionary and ultimately, the delivery of truly personalized care to every patient.
VerstraetenALuyckxILoeysB.Aetiology and management of hereditary aortopathy. Nat Rev Cardiol2017;
14: 197–208.
2.
PapeLATsaiTTIsselbacherEM, et al.
Aortic diameter > or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation2007;
116: 1120–1127.
3.
HowardDPBanerjeeAFairheadJFPerkinsJSilverLERothwellPM.Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation2013;
127: 2031–2037.
4.
EvangelistaAIsselbacherEMBossoneE, et al.
Insights from the International Registry of Acute Aortic Dissection: a 20-year experience of collaborative clinical research.Circulation2018;
137: 1846–1860.
5.
ZiganshinBAElefteriadesJA. Genetic impact on thoracic aortic aneurysms. In: Eskandari MK, Pearce WK, Yao JST, editors. Current Vascular Surgery: Northwestern Vascular Symposium. PMPH-USA, Ltd., 2017: 461–480.
6.
ElefteriadesJABrownsteinAJZiganshinBA.Clinical and molecular genetics of thoracic aortic aneurysm and dissection. In: ChiesaRMelissanoG, editors. Aortic Dissection: Patients True Stories and the Innovations That Saved Their Lives.
Milan, Italy:
Edi.Ermes, 2016: 49–80.
7.
MilewiczDHostetlerEWallaceS, et al.
Precision medical and surgical management for thoracic aortic aneurysms and acute aortic dissections based on the causative mutant gene. J Cardiovasc Surg (Torino)2016;
57: 172–177.
8.
AlbornozGCoadyMARobertsM, et al.
Familial thoracic aortic aneurysms and dissections—incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg2006;
82: 1400–1405.
9.
BiddingerARocklinMCoselliJMilewiczDM.Familial thoracic aortic dilatations and dissections: a case control study.J Vasc Surg1997;
25: 506–511.
10.
ElefteriadesJAFarkasEA.Thoracic aortic aneurysm clinically pertinent controversies and uncertainties.J Am Coll Cardiol2010;
55: 841–857.
11.
SherrahAGAndvikSvan der LindeD, et al.
Nonsyndromic thoracic aortic aneurysm and dissection: outcomes with Marfan syndrome versus bicuspid aortic valve aneurysm. J Am Coll Cardiol2016;
67: 618–626.
12.
MilewiczDMRegaladoE.Heritable thoracic aortic disease overview. In: AdamMPArdingerHHPagonRAWallaceSEBeanLJHStephensKAmemiyaA, editors. GeneReviews.
Seattle WA:
University of Washington, 1993.
13.
ChouASMaWGMokSC, et al.
Do familial aortic dissections tend to occur at the same age?Ann Thorac Surg2017;
103: 546–450.
14.
MilewiczDMChenHParkES, et al.
Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections.Am J Cardiol1998;
82: 474–479.
15.
LuyckxILoeysBL.The genetic architecture of non-syndromic thoracic aortic aneurysm.Heart2015;
101: 1678–1684.
16.
WeinsaftJWDevereuxRBPreissLR, et al.
Aortic dissection in patients with genetically mediated aneurysms: incidence and predictors in the GenTAC Registry. J Am Coll Cardiol2016;
67: 2744–2754.
17.
den HartogAWFrankenRZwindermanAH, et al.
The risk for type B aortic dissection in Marfan syndrome.J Am Coll Cardiol2015;
65: 246–254.
18.
TakedaNInuzukaRMaemuraS, et al.
Impact of pathogenic FBN1 variant types on the progression of aortic disease in patients with Marfan syndrome. Circ Genom Precis Med2018;
11: e002058.
19.
BaudhuinLMKotzerKELagerstedtSA.Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Med2015;
17: 177–187.
20.
FrankenRGroeninkMde WaardV, et al.
Genotype impacts survival in Marfan syndrome. Eur Heart J2016;
37: 3285–3290.
21.
AndelfingerGLoeysBDietzH.A decade of discovery in the genetic understanding of thoracic aortic disease.Can J Cardiol2016;
32: 13–25.
22.
HiratzkaLFBakrisGLBeckmanJA, et al.
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.J Am Coll Cardiol2010;
55: e27–129.
23.
RegaladoESGuoDCSantos-CortezRL, et al.
Pathogenic FBN1 variants in familial thoracic aortic aneurysms and dissections.Clin Genet2016;
89: 719–723.
24.
MacCarrickGBlackJH3rdBowdinS, et al.
Loeys-Dietz syndrome: a primer for diagnosis and management.Genet Med2014;
16: 576–587.
25.
HostetlerEMRegaladoESGuoDC, et al.
SMAD3 pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium.J Med Genet2019;
56: 252–260.
26.
JondeauGRopersJRegaladoE, et al.
International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: results of the MAC (Montalcino Aortic Consortium).Circ Cardiovasc Genet2016;
9: 548–558.
27.
ErbelRAboyansVBoileauC, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).Eur Heart J2014;
35: 2873–2926.
28.
PepinMGSchwarzeURiceKMLiuMLeistritzDByersPH.Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV).Genet Med2014;
16: 881–888.
29.
GillisEVan LaerLLoeysBL.Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-beta signaling and vascular smooth muscle cell contractility.Circ Res2013;
113: 327–340.
30.
GermainDP.Ehlers-Danlos syndrome type IV.Orphanet J Rare Dis2007;
2: 32.
31.
ShalhubSBlackJH3rdCecchiAC, et al.
Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes. J Vasc Surg2014;
60: 160–169.
32.
FrankMAlbuissonJRanqueB, et al.
The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome.Eur J Hum Genet2015;
23: 1657–1664.
33.
DisabellaEGrassoMGambarinFI, et al.
Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2).Heart2011;
97: 321–326.
34.
WangLGuoDCCaoJ, et al.
Mutations in myosin light chain kinase cause familial aortic dissections.Am J Hum Genet2010;
87: 701–707.
35.
GuoDCPannuHTran-FaduluV, et al.
Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.Nat Genet2007;
39: 1488–1493.
36.
MorisakiHAkutsuKOginoH, et al.
Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD).Hum Mutat2009;
30: 1406–1411.
37.
RegaladoESGuoDCPrakashS, et al.
Aortic disease presentation and outcome associated with ACTA2 mutations.Circ Cardiovasc Genet2015;
8: 457–464.
38.
MilewiczDMRegaladoES.Use of genetics for personalized management of heritable thoracic aortic disease: how do we get there?J Thorac Cardiovasc Surg2015;
149: S3–5.
39.
WallaceSERegaladoESGongL, et al.
MYLK pathogenic variants aortic disease presentation, pregnancy risk, and characterization of pathogenic missense variants.Genet Med2019;
21: 144–1451.
40.
GuoDCHostetlerEMFanY, et al.
Heritable thoracic aortic disease genes in sporadic aortic dissection.J Am Coll Cardiol2017;
70: 2728–2730.
41.
OverwaterEMarsiliLBaarsMJH, et al.
Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders.Hum Mutat2018;
39: 1173–1192.
42.
PrakashSKuangSQ; GenTAC Registry Investigators, Regalado E, Guo D, Milewicz D.Recurrent rare genomic copy number variants and bicuspid aortic valve are enriched in early onset thoracic aortic aneurysms and dissections.PLoS One2016;
11: e0153543.
43.
IakoubovaOATongCHCataneseJ, et al.
KIF6 719Arg genetic variant and risk for thoracic aortic dissection.Aorta (Stamford)2016;
4: 83–90.
44.
GuoDCGroveMLPrakashSK, et al.
Genetic variants in LRP1 and ULK4 are associated with acute aortic dissections.Am J Hum Genet2016;
99: 762–9.
45.
ZiganshinBABaileyAECoonsC, et al.
Routine genetic testing for thoracic aortic aneurysm and dissection in a clinical setting.Ann Thorac Surg2015;
100: 1604–11.
46.
KwartlerCSGongLChenJ, et al.
Variants of unknown significance in genes associated with heritable thoracic aortic disease can be low penetrant "risk variants".Am J Hum Genet2018;
103: 138–143.
47.
AubartMGazalSArnaudP, et al.
Association of modifiers and other genetic factors explain Marfan syndrome clinical variability.Eur J Hum Genet2018;
26: 1759–1772.
48.
BrownsteinAJZiganshinBAKuivaniemiHBodySCBaleAEElefteriadesJA.Genes associated with thoracic aortic aneurysm and dissection: an update and clinical implications.Aorta (Stamford)2017;
5: 11–20.
49.
Faggion VinholoTBrownsteinAJZiganshinBA, et al.
Genes associated with thoracic aortic aneurysm and dissection: 2019 update and clinical implications.Aorta (Stamford)2019;
7: 99–107.
50.
Wooderchak-DonahueWVanSant-WebbCTvrdikT, et al.
Clinical utility of a next generation sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy.Am J Med Genet A2015;
167A: 1747–1757.
51.
WeerakkodyRRossDParryDA, et al.
Targeted genetic analysis in a large cohort of familial and sporadic cases of aneurysm or dissection of the thoracic aorta.Genet Med2018;
20: 1414–1422.
YangHLuoMFuY, et al.
Genetic testing of 248 Chinese aortopathy patients using a panel assay.Sci Rep2016;
6: 33002.
54.
PoninskaJKBilinskaZTFranaszczykM, et al.
Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations.J Transl Med2016;
14: 115.
55.
ZiganshinBABaileyAEBrownsteinAJTranquilliMBaleAEElefteriadesJA.Identification of genetic defects causing thoracic aortic aneurysm by whole exome sequencing: experience in 211 patients. Western Thoracic Surgical Association 43rd Annual Meeting. Colorado Springs, Colorado 2017.
56.
CampensLCallewaertBMuino MosqueraL, et al.
Gene panel sequencing in heritable thoracic aortic disorders and related entities - results of comprehensive testing in a cohort of 264 patients.Orphanet J Rare Dis2015;
10: 9.
57.
SchubertJALandisBJShikanyARHintonRBWareSM.Clinically relevant variants identified in thoracic aortic aneurysm patients by research exome sequencing.Am J Med Genet A2016;
170A: 1288–1294.
58.
LandisBJSchubertJALaiD, et al.
Exome sequencing identifies candidate genetic modifiers of syndromic and familial thoracic aortic aneurysm severity.J Cardiovasc Transl Res2017;
10: 423–432.
59.
ProostDVandeweyerGMeesterJA, et al.
Performant mutation identification using targeted next-generation sequencing of 14 thoracic aortic aneurysm genes.Hum Mutat2015;
36: 808–814.
60.
WangYBarbacioruCCShiffmanD, et al.
Gene expression signature in peripheral blood detects thoracic aortic aneurysm.PLoS One2007;
2: e1050.
61.
Faggion VinholoTBrownsteinAJZiganshinBA, et al.
Genes associated with thoracic aortic aneurysm and dissection: 2019 update and clinical implications.Aorta (Stamford)2019;
7: 99–107.
62.
MilewiczDMPrakashSKRamirezF.Therapeutics targeting drivers of thoracic aortic aneurysms and acute aortic dissections: insights from predisposing genes and mouse models. Annu Rev Med2017;
68: 51–67.
63.
MilewiczDHostetlerEWallaceS, et al.
Precision medical and surgical management for thoracic aortic aneurysms and acute aortic dissections based on the causative mutant gene. J Cardiovasc Surg (Torino)2016;
57: 172–177.
64.
BradleyTJBowdinSCMorelCFPyeritzRE.The expanding clinical spectrum of extracardiovascular and cardiovascular manifestations of heritable thoracic aortic aneurysm and dissection. Can J Cardiol2016;
32: 86–99.
65.
AndelfingerGLoeysBDietzH.A decade of discovery in the genetic understanding of thoracic aortic disease. Can J Cardiol2016;
32: 13–25.
66.
DisabellaEGrassoMGambarinFI, et al.
Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2). Heart2011;
97: 321–326.
67.
GuoDCPannuHTran-FaduluV, et al.
Mutations in smooth muscle alpha–actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet2007;
39: 1488–93.
68.
TanKLHaeltermanNAKwartlerCS, et al.
Ari-1 regulates myonuclear organization together with parkin and is associated with aortic aneurysms. Dev Cell2018;
45: 226–44 e8.
69.
HeegaardAMCorsiADanielsenCC, et al.
Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation2007;
115: 2731–2738.
70.
MeesterJAVandeweyerGPintelonI, et al.
Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections. Genet Med2017;
19: 386–395.
71.
SchwarzeUHataRMcKusickVA, et al.
Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet2004;
74: 917–930.
72.
SmithLBHadokePWDyerE, et al.
Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome. Cardiovasc Res2011;
90: 182–190.
73.
D'HondtSGuillemynBSyxD, et al.
Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model. Matrix Biol2018;
70: 72–83.
74.
Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2873–2926.
75.
GermainDP.Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis2007;
2: 32.
76.
De PaepeAMalfaitF.The Ehlers-Danlos syndrome, a disorder with many faces. Clin Genet2012;
82: 1–11.
77.
MonroeGRHarakalovaMvan der CrabbenSN, et al.
Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1. Am J Med Genet A2015;
167: 1196–1203.
78.
MehtaSDharSUBirnbaumY.Common iliac artery aneurysm and spontaneous dissection with contralateral iatrogenic common iliac artery dissection in classic Ehlers-Danlos syndrome. Int J Angiol2012;
21: 167–170.
79.
WenstrupRJMeyerRALyleJS, et al.
Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet Med2002;
4: 112–117.
80.
ParkACPhanNMassoudiD, et al.
Deficits in Col5a2 expression result in novel skin and adipose abnormalities and predisposition to aortic aneurysms and dissections. Am J Pathol. 2017;
187: 2300–2311.
81.
HuangJDavisECChapmanSL, et al.
Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression. Circ Res2010;
106: 583–592.
82.
IgouchevaOAlexeevVHalabiCM, et al.
Fibulin-4 E57K knock-in mice recapitulate cutaneous, vascular and skeletal defects of recessive cutis laxa 1B with both elastic fiber and collagen fibril abnormalities. J Biol Chem2015;
290: 21443–21459.
83.
. Loeys B, De Paepe A, Urban Z. EFEMP2-Related Cutis Laxa. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews. Seattle WA: University of Washington, 1993.
84.
JelsigAMUrbanZHucthagowderVNissenHOusagerLB.Novel ELN mutation in a family with supravalvular aortic stenosis and intracranial aneurysm. Eur J Med Genet2017;
60: 110–113.
85.
CallewaertBRenardMHucthagowderV, et al.
New insights into the pathogenesis of autosomal-dominant cutis laxa with report of five ELN mutations. Hum Mutat2011;
32: 445–55.
86.
SzaboZCrepeauMWMitchellAL, et al.
Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene. J Med Genet2006;
43: 255–258.
87.
CapuanoABucciottiFFarwellKD, et al.
Diagnostic exome sequencing identifies a novel gene, EMILIN1, associated with autosomal-dominant hereditary connective tissue disease. Hum Mutat2016;
37: 84–97.
88.
PereiraLAndrikopoulosKTianJ, et al.
Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet1997;
17: 218–22.
89.
PereiraLLeeSYGayraudB, et al.
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A1999;
96: 3819–3823.
90.
JudgeDPBieryNJKeeneDR, et al.
Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest2004;
114: 172–181.
91.
HabashiJPJudgeDPHolmTM, et al.
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science2006;
312: 117–121.
92.
LimaBLSantosEJFernandesGR, et al. A
new mouse model for marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of Fbn1 expression. PLoS One2010;
5: e14136.
93.
MorrisSAOrbachDBGevaTSinghMNGauvreauKLacroRV.Increased vertebral artery tortuosity index is associated with adverse outcomes in children and young adults with connective tissue disorders. Circulation2011;
124: 388–396.
94.
HiratzkaLFBakrisGLBeckmanJA, et al.
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine.J Am Coll Cardiol2010;
55: e27–129.
95.
TakedaNMoritaHFujitaD, et al.
Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: case report and review of literature. Am J Med Genet A2015;
167A: 2382–2387.
96.
RetailleauKArhatteMDemolombeS, et al.
Smooth muscle filamin A is a major determinant of conduit artery structure and function at the adult stage. Pflugers Arch2016;
468: 1151–60.
97.
FengYChenMHMoskowitzIP, et al.
Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci U S A2006;
103: 19836–41.
98.
ReinsteinEFrentzSMorganT, et al.
Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A. Eur J Hum Genet2013;
21: 494–502.
99.
LangeMKasperBBohringA, et al.
47 patients with FLNA associated periventricular nodular heterotopia. Orphanet J Rare Dis2015;
10: 134.
100.
KuangSQMedina-MartinezOGuoDC, et al.
FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. J Clin Invest2016;
126: 948–961.
101.
VermeerAMCLodderEMThomasD, et al.
Dilation of the Aorta Ascendens Forms Part of the Clinical Spectrum of HCN4 Mutations. J Am Coll Cardiol2016;
67: 2313–2315.
102.
LeeVSHalabiCMHoffmanEP, et al.
Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans. Proc Natl Acad Sci U S A2016;
113: 8759–64.
103.
HornstraIKBirgeSStarcherBBaileyAJMechamRPShapiroSD.Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem2003;
278: 14387–14393.
104.
MakiJMRasanenJTikkanenH, et al.
Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation2002;
106: 2503–9.
105.
RenWLiuYWangX, et al. beta-
Aminopropionitrile monofumarate induces thoracic aortic dissection in C57BL/6 mice. Sci Rep2016;
6: 28149.
106.
Quinones-PerezBVanNoyGETowneMC, et al.
Three-generation family with novel contiguous gene deletion on chromosome 2p22 associated with thoracic aortic aneurysm syndrome. Am J Med Genet A2018;
176: 560–569.
107.
GuoDCRegaladoESPinardA, et al.
LTBP3 pathogenic variants predispose individuals to thoracic aortic aneurysms and dissections. Am J Hum Genet2018;
102: 706–712.
108.
MorkmuedSHemmerleJMathieuE, et al.
Enamel and dental anomalies in latent-transforming growth factor beta-binding protein 3 mutant mice. Eur J Oral Sci2017;
125: 8–17.
109.
DabovicBChenYColarossiC, et al.
Bone abnormalities in latent TGF-[beta] binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-[beta] bioavailability. J Cell Biol2002;
156: 227–232.
110.
GuoDCGongLRegaladoES, et al.
MAT2A mutations predispose individuals to thoracic aortic aneurysms. Am J Hum Genet2015;
96: 170–7.
111.
CombsMDKnutsenRHBroekelmannTJ, et al.
Microfibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo. J Biol Chem2013;
288: 28869–28880.
112.
BarbierMGrossMSAubartM, et al.
MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet2014;
95: 736–743.
113.
BelliniCWangSMilewiczDMHumphreyJD.Myh11(R247C/R247C) mutations increase thoracic aorta vulnerability to intramural damage despite a general biomechanical adaptivity. J Biomech2015;
48: 113–121.
114.
PannuHTran-FaduluVPapkeCL, et al.
MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet2007;
16: 2453–2462.
115.
WangLGuoDCCaoJ, et al.
Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet2010;
87: 701–7.
116.
ShalataAMahroomMMilewiczDM, et al.
Fatal thoracic aortic aneurysm and dissection in a large family with a novel MYLK gene mutation: delineation of the clinical phenotype. Orphanet J Rare Dis2018;
13: 41.
117.
HannukselaMStattinELKlarJ, et al.
A novel variant in MYLK causes thoracic aortic dissections: genotypic and phenotypic description. BMC Med Genet2016;
17: 61.
118.
LuyckxIProostDHendriksJMH, et al.
Two novel MYLK nonsense mutations causing thoracic aortic aneurysms/dissections in patients without apparent family history. Clin Genet2017;
92: 444–446.
119.
ProostDVandeweyerGMeesterJA, et al.
Performant mutation identification using targeted next-generation sequencing of 14 thoracic aortic aneurysm genes. Hum Mutat2015;
36: 808–814.
120.
McKellarSHTesterDJYagubyanMMajumdarRAckermanMJSundtTM3rd.Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg2007;
134: 290–296.
121.
GuoDCRegaladoECasteelDE, et al.
Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet2013;
93: 398–404.
122.
GouldRAAzizHWoodsCE, et al.
ROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm. Nat Genet2019;
51: 42–50.
123.
DoyleAJDoyleJJBesslingSL, et al.
Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet2012;
44: 1249–1254.
124.
CallewaertBLWillaertAKerstjens-FrederikseWS, et al.
Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat2008;
29: 150–158.
125.
MichaDGuoDCHilhorst-HofsteeY, et al.
SMAD2 mutations are associated with arterial aneurysms and dissections. Hum Mutat2015;
36: 1145–1149.
126.
ZhangWZengQXuY, et al.
Exome sequencing identified a novel SMAD2 mutation in a Chinese family with early onset aortic aneurysms. Clin Chim Acta2017;
468: 211–214.
127.
Tan CK, Tan EH, Luo B, et al. SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS. J Am Heart Assoc 2013; 2: e000269.
128.
van der LindeDvan de LaarIMBertoli-AvellaAM, et al.
Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. J Am Coll Cardiol2012;
60: 397–403.
129.
van de LaarIMvan der LindeDOeiEH, et al.
Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet2012;
49: 47–57.
130.
ZhangPHouSChenJ, et al.
Smad4 deficiency in smooth muscle cells initiates the formation of aortic aneurysm. Circ Res2016;
118: 388–399.
131.
HealdBRigelskyCMoranR, et al.
Prevalence of thoracic aortopathy in patients with juvenile polyposis syndrome-hereditary hemorrhagic telangiectasia due to SMAD4. Am J Med Genet A2015;
167A: 1758–1762.
132.
WainKEEllingsonMSMcDonaldJ, et al.
Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review. Genet Med2014;
16: 588–593.
133.
GillisEKumarAALuyckxI, et al.
Candidate gene resequencing in a large bicuspid aortic valve-associated thoracic aortic aneurysm cohort: SMAD6 as an important contributor. Front Physiol2017;
8: 400.
134.
CorbittHMorrisSAGravholtCH, et al.
TIMP3 and TIMP1 are risk genes for bicuspid aortic valve and aortopathy in Turner syndrome. PLoS Genet2018;
14: e1007692.
135.
LindsayMESchepersDBolarNA, et al.
Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet2012;
44: 922–927.
136.
BoileauCGuoDCHannaN, et al.
TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet2012;
44: 916–921.
137.
RenardMCallewaertBMalfaitF, et al.
Thoracic aortic-aneurysm and dissection in association with significant mitral valve disease caused by mutations in TGFB2. Int J Cardiol2013;
165: 584–587.
138.
Bertoli-AvellaAMGillisEMorisakiH, et al.
Mutations in a TGF-beta ligand, TGFB3, cause syndromic aortic aneurysms and dissections. J Am Coll Cardiol2015;
65: 1324–1336.
139.
GalloEMLochDCHabashiJP, et al.Angiotensin II-dependent TGF-beta signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest2014;
124: 448–460.
140.
MacCarrickGBlackJH3rdBowdinS, et al.Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med2014;
16: 576–587.
141.
JondeauGRopersJRegaladoE, et al.
International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: results of the MAC (Montalcino Aortic Consortium). Circ Cardiovasc Genet2016;
9: 548–558.
142.
BoodhwaniMAndelfingerGLeipsicJ, et al.
Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. CanJ Cardiol2014;
30: 577–589.
143.
AttiasDStheneurCRoyC, et al.
Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation2009;
120: 2541–2549.
144.
Teixido-TuraGFrankenRGaluppoV, et al.
Heterogeneity of aortic disease severity in patients with Loeys-Dietz syndrome. Heart2016;
102: 626–632.
145.
Tran-FaduluVPannuHKimDH, et al.
Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet2009;
46: 607–613.
146.
WenstrupRJFlorerJBDavidsonJM, et al.
Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem2006;
281: 12888–12895.
147.
ParkACPhillipsCLPfeifferFM, et al.
Homozygosity and heterozygosity for null Col5a2 alleles produce embryonic lethality and a novel classic Ehlers-Danlos syndrome-related phenotype. Am J Pathol2015;
185: 2000–11.
148.
TodorovicVFrendeweyDGutsteinDE, et al.
Long form of latent TGF-beta binding protein 1 (Ltbp1L) is essential for cardiac outflow tract septation and remodeling. Development2007;
134: 3723–3732.
149.
KuangSQKwartlerCSByanovaKL, et al.
Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells. Circ Res2012;
110: 1411–22.
150.
KoenigSNLaHayeSFellerJD, et al.
Notch1 haploinsufficiency causes ascending aortic aneurysms in mice. JCI Insight2017;
2:e91353.
151.
BerkMDesaiSYHeymanHCColmenaresC.Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development. Genes Dev1997;
11: 2029–2039.
152.
ZoppiNChiarelliNCinquinaVRitelliMColombiM.GLUT10 deficiency leads to oxidative stress and non-canonical alphavbeta3 integrin-mediated TGFbeta signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts. Hum Mol Genet2015;
24: 6769–6787.
153.
ChengCHKikuchiTChenYH, et al.
Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc Res 2009;
81: 381–388.
154.
GalvinKMDonovanMJLynchCA, et al.
A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet2000;
24: 171–174.
155.
AzharMSchultz JelJGruppI, et al.
Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev2003;
14: 391–407.
